Khushboo Saran
Khushboo Saran has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Jay Prakash
Department of Critical Care Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India
8 shared publications - Amit Kumar
Department of Lab Medicine, RIMS, Ranchi, India
3 shared publications - Bodhisatwa Choudhuri
Department of Critical Care, College of Medicine and Veterinary Medicine University of Edinburgh Edinburgh UK
3 shared publications - Pradip Kumar Bhattacharya
Department of Critical Care Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India
3 shared publications - Archana Kumari
Department of Obstetrics and Gynecology, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India
2 shared publications - Kunal Raj
Department of Critical Care Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India
2 shared publications
Latest Publications
- Open Access
- 17 April 2026
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 30 (4) , 357-358
Diagnostic Accuracy of Point-of-care Ultrasonography for Endotracheal Tube Confirmation: Interpreting Evidence beyond Pooled Estimates
How to cite this article: Prakash J, Saran K, Swarna K, Choudhuri B, Gupta BK. Diagnostic Accuracy of Point-of-care Ultrasonography for Endotracheal Tube Confirmation: Interpreting Evidence beyond Pooled Estimates. Indian J Crit Care Med 2026;30(4):357–358.
- 17 April 2026
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 30 (4) , 357-358
Open AccessDiagnostic Accuracy of Point-of-care Ultrasonography for Endotracheal Tube Confirmation: Interpreting Evidence beyond Pooled Estimates
How to cite this article: Prakash J, Saran K, Swarna K, Choudhuri B, Gupta BK. Diagnostic Accuracy of Point-of-care Ultrasonography for Endotracheal Tube Confirmation: Interpreting Evidence beyond Pooled Estimates. Indian J Crit Care Med 2026;30(4):357–358.
- Open Access
- 13 February 2026
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 30 (2) , 182-183
C-reactive Protein-to-albumin Ratio (CAR) in Polytrauma—Early Warning or Marker of Disease Evolution?
How to cite this article: Saran K, Choudhuri B, Priye S, Prakash J. C-reactive Protein-to-albumin Ratio (CAR) in Polytrauma—Early Warning or Marker of Disease Evolution? Indian J Crit Care Med 2026;30(2):182–183.
- 13 February 2026
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 30 (2) , 182-183
Open AccessC-reactive Protein-to-albumin Ratio (CAR) in Polytrauma—Early Warning or Marker of Disease Evolution?
How to cite this article: Saran K, Choudhuri B, Priye S, Prakash J. C-reactive Protein-to-albumin Ratio (CAR) in Polytrauma—Early Warning or Marker of Disease Evolution? Indian J Crit Care Med 2026;30(2):182–183.
- Open Access
- 18 October 2025
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 29 (10) , 799-801
Early Vasopressin in Septic Shock—Promise, Paradox, and the Pursuit of Precision
How to cite this article: Prakash J, Saran K, Choudhuri B. Early Vasopressin in Septic Shock—Promise, Paradox, and the Pursuit of Precision. Indian J Crit Care Med 2025;29(10):799–801.
- 18 October 2025
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 29 (10) , 799-801
Open AccessEarly Vasopressin in Septic Shock—Promise, Paradox, and the Pursuit of Precision
How to cite this article: Prakash J, Saran K, Choudhuri B. Early Vasopressin in Septic Shock—Promise, Paradox, and the Pursuit of Precision. Indian J Crit Care Med 2025;29(10):799–801.
- Open Access
- 8 May 2025
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 29 (5) , 449-457
Bayesian Analysis of Modified Nutrition Risk in Critically Ill (mNUTRIC) Score for Mortality Prediction in Critically Ill Patients
Malnutrition has a considerable influence on critically ill patients by increasing mortality and poorer clinical outcomes. The modified Nutrition Risk in Critically Ill (mNUTRIC) score is commonly used to assess nutritional risk and predict death; however, its sensitivity, specificity, and optimal cut-off values differ between studies. This study uses a Bayesian approach to assess the accuracy of the mNUTRIC score in predicting mortality in critically ill patients. A preplanned Bayesian analysis was performed using data from 31 cohort studies, which included 13,271 intensive care unit (ICU) patients. The study investigated the mNUTRIC score's sensitivity, specificity, diagnostic odds ratio, and area under the curve (AUC). Subgroup analysis compared mortality rates at 28-day, 90-day, and in-hospital time points, along with cut-off values (et al. Bayesian Analysis of Modified Nutrition Risk in Critically Ill (mNUTRIC) Score for Mortality Prediction in Critically Ill Patients. Indian J Crit Care Med 2025;29(5):449-457.
- 8 May 2025
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 29 (5) , 449-457
Open AccessBayesian Analysis of Modified Nutrition Risk in Critically Ill (mNUTRIC) Score for Mortality Prediction in Critically Ill Patients
Malnutrition has a considerable influence on critically ill patients by increasing mortality and poorer clinical outcomes. The modified Nutrition Risk in Critically Ill (mNUTRIC) score is commonly used to assess nutritional risk and predict death; however, its sensitivity, specificity, and optimal cut-off values differ between studies. This study uses a Bayesian approach to assess the accuracy of the mNUTRIC score in predicting mortality in critically ill patients. A preplanned Bayesian analysis was performed using data from 31 cohort studies, which included 13,271 intensive care unit (ICU) patients. The study investigated the mNUTRIC score's sensitivity, specificity, diagnostic odds ratio, and area under the curve (AUC). Subgroup analysis compared mortality rates at 28-day, 90-day, and in-hospital time points, along with cut-off values (et al. Bayesian Analysis of Modified Nutrition Risk in Critically Ill (mNUTRIC) Score for Mortality Prediction in Critically Ill Patients. Indian J Crit Care Med 2025;29(5):449-457.
- Open Access
- 30 December 2024
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 29 (1) , 6-7
Controlling Glycemic Variability in Non-diabetic Sepsis Patients: A Step toward Precision in Critical Care
How to cite this article: Prakash J, Vaibhaw V, Saran K. Controlling Glycemic Variability in Non-diabetic Sepsis Patients: A Step toward Precision in Critical Care. Indian J Crit Care Med 2025;29(1):6–7.
- 30 December 2024
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 29 (1) , 6-7
Open AccessControlling Glycemic Variability in Non-diabetic Sepsis Patients: A Step toward Precision in Critical Care
How to cite this article: Prakash J, Vaibhaw V, Saran K. Controlling Glycemic Variability in Non-diabetic Sepsis Patients: A Step toward Precision in Critical Care. Indian J Crit Care Med 2025;29(1):6–7.
- Open Access
- 30 April 2024
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 28 (5) , 495-503
Modified NUTRIC Score as a Predictor of All-cause Mortality in Critically Ill Patients: A Systematic Review and Meta-analysis
The purpose of our meta-analysis was to look at the impact of modified nutrition risk in the critically ill (mNUTRIC) on mortality in patients with critical illness. Literature relevant to this meta-analysis was searched in PubMed, Web of Science, and Cochrane Library till 26 August 2023. Prospective or retrospective studies, patients >18 years of age, studies that reported on mortality and mNUTRIC (mNUTRIC cut-off score) were included. The QUIPS tool was used to evaluate the risk for bias in prognostic factors. A total of 31 studies on mNUTRIC score, involving 13,271 patients were included. The summary area under the curve (sAUC) of 0.80 (95% CI: 0.76–0.83) illustrates the mNUTRIC score's strong discrimination. The pooled sensitivity was 0.79 (95% CI: 0.74–0.84) and pooled specificity was 0.68 (95% CI: 0.63–0.73). We found no discernible variation in the mNUTRIC's prediction accuracy among cut-off values of 5 in our subgroup analysis and sAUC values were 0.82 (95% CI: 0.78–0.85) and 0.78 (95% CI: 0.74–0.81), respectively. We observed that mNUTRIC can discriminate between critically ill individuals and predict their mortality. CRD42023460292 Prakash J, Verma S, Shrivastava P, Saran K, Kumari A, Raj K, et al. Modified NUTRIC Score as a Predictor of All-cause Mortality in Critically Ill Patients: A Systematic Review and Meta-analysis. Indian J Crit Care Med 2024;28(5):495–503.
- 30 April 2024
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 28 (5) , 495-503
Open AccessModified NUTRIC Score as a Predictor of All-cause Mortality in Critically Ill Patients: A Systematic Review and Meta-analysis
The purpose of our meta-analysis was to look at the impact of modified nutrition risk in the critically ill (mNUTRIC) on mortality in patients with critical illness. Literature relevant to this meta-analysis was searched in PubMed, Web of Science, and Cochrane Library till 26 August 2023. Prospective or retrospective studies, patients >18 years of age, studies that reported on mortality and mNUTRIC (mNUTRIC cut-off score) were included. The QUIPS tool was used to evaluate the risk for bias in prognostic factors. A total of 31 studies on mNUTRIC score, involving 13,271 patients were included. The summary area under the curve (sAUC) of 0.80 (95% CI: 0.76–0.83) illustrates the mNUTRIC score's strong discrimination. The pooled sensitivity was 0.79 (95% CI: 0.74–0.84) and pooled specificity was 0.68 (95% CI: 0.63–0.73). We found no discernible variation in the mNUTRIC's prediction accuracy among cut-off values of 5 in our subgroup analysis and sAUC values were 0.82 (95% CI: 0.78–0.85) and 0.78 (95% CI: 0.74–0.81), respectively. We observed that mNUTRIC can discriminate between critically ill individuals and predict their mortality. CRD42023460292 Prakash J, Verma S, Shrivastava P, Saran K, Kumari A, Raj K, et al. Modified NUTRIC Score as a Predictor of All-cause Mortality in Critically Ill Patients: A Systematic Review and Meta-analysis. Indian J Crit Care Med 2024;28(5):495–503.
- Open Access
- 13 December 2023
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 67 (12) , 1029-1035
Role of Mycobacterium indicus pranii in clinical outcomes in patients with sepsis: A systematic review and meta-analysis of randomised controlled trials
Background and Aims: Sepsis-induced immunosuppression appears to be reversible with immunomodulatory drugs. Mycobacterium indicus pranii (MIP) stimulates the Th1 type of immune response. This systematic review and meta-analysis of randomised controlled trials (RCTs) was aimed to find out if MIP is effective at improving clinical outcomes in sepsis patients. Methods: The databases (PubMed, Google Scholar, Web of Science, and Cochrane Library), along with preprint servers until June 2023, were searched. The methodology was evaluated using the ‘Cochrane Collaboration risk of bias-2 tool’ for RCT. The study included patients more than 18 years of age with sepsis within 48 h of first organ dysfunction. The primary outcome was 28-day mortality, and secondary outcomes were the length of stay in the intensive care unit (ICU), days on vasopressor support, ventilator-associated pneumonia (VAP), secondary infections, catheter-related bloodstream infections (CRBSI), and the delta sequential organ failure assessment (SOFA) score. Results: The meta-analysis included two studies with 252 participants. In a pooled analysis, mortality in the MIP group was 43% lower than in the control (RR: 0.57, 95%CI: 0.33–1); however, this difference was statistically not significant. We observed the days on a vasopressor day (standardised mean difference [SMD]: 0.38; 95%CI: −1.20 to 0.44), length of ICU stay (SMD: 0.46; 95%CI: −1.44 to 0.51), secondary infection (RR: 0.75; 95%CI: 0.19–3.01), VAP (RR: 0.6; 95%CI: 0.28–1.56), CRBSI (RR: 0.97, 95%CI: 0.14–6.98), delta SOFA score (SMD: 0.88, 95%CI: −1.66 to − 0.10) between the two groups. Conclusions: Our findings observed preliminary evidence in the trends for a positive association of MIP with better outcomes in sepsis patients.
- 13 December 2023
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 67 (12) , 1029-1035
Open AccessRole of Mycobacterium indicus pranii in clinical outcomes in patients with sepsis: A systematic review and meta-analysis of randomised controlled trials
Background and Aims: Sepsis-induced immunosuppression appears to be reversible with immunomodulatory drugs. Mycobacterium indicus pranii (MIP) stimulates the Th1 type of immune response. This systematic review and meta-analysis of randomised controlled trials (RCTs) was aimed to find out if MIP is effective at improving clinical outcomes in sepsis patients. Methods: The databases (PubMed, Google Scholar, Web of Science, and Cochrane Library), along with preprint servers until June 2023, were searched. The methodology was evaluated using the ‘Cochrane Collaboration risk of bias-2 tool’ for RCT. The study included patients more than 18 years of age with sepsis within 48 h of first organ dysfunction. The primary outcome was 28-day mortality, and secondary outcomes were the length of stay in the intensive care unit (ICU), days on vasopressor support, ventilator-associated pneumonia (VAP), secondary infections, catheter-related bloodstream infections (CRBSI), and the delta sequential organ failure assessment (SOFA) score. Results: The meta-analysis included two studies with 252 participants. In a pooled analysis, mortality in the MIP group was 43% lower than in the control (RR: 0.57, 95%CI: 0.33–1); however, this difference was statistically not significant. We observed the days on a vasopressor day (standardised mean difference [SMD]: 0.38; 95%CI: −1.20 to 0.44), length of ICU stay (SMD: 0.46; 95%CI: −1.44 to 0.51), secondary infection (RR: 0.75; 95%CI: 0.19–3.01), VAP (RR: 0.6; 95%CI: 0.28–1.56), CRBSI (RR: 0.97, 95%CI: 0.14–6.98), delta SOFA score (SMD: 0.88, 95%CI: −1.66 to − 0.10) between the two groups. Conclusions: Our findings observed preliminary evidence in the trends for a positive association of MIP with better outcomes in sepsis patients.
- 16 February 2023
- Published by Elsevier in Journal of Medical Imaging and Radiation Sciences
- Vol. 54 (2) , 364-375
Computed tomography severity score as a predictor of disease severity and mortality in COVID-19 patients: A systematic review and meta-analysis
- 16 February 2023
- Published by Elsevier in Journal of Medical Imaging and Radiation Sciences
- Vol. 54 (2) , 364-375
Computed tomography severity score as a predictor of disease severity and mortality in COVID-19 patients: A systematic review and meta-analysis